Vetting Matthew W, Hegde Subray S, Javid-Majd Farah, Blanchard John S, Roderick Steven L
Department of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA.
Nat Struct Biol. 2002 Sep;9(9):653-8. doi: 10.1038/nsb830.
AAC(2')-Ic catalyzes the coenzyme A (CoA)-dependent acetylation of the 2' hydroxyl or amino group of a broad spectrum of aminoglycosides. The crystal structure of the AAC(2')-Ic from Mycobacterium tuberculosis has been determined in the apo enzyme form and in ternary complexes with CoA and either tobramycin, kanamycin A or ribostamycin, representing the first structures of an aminoglycoside acetyltransferase bound to a drug. The overall fold of AAC(2')-Ic places it in the GCN5-related N-acetyltransferase (GNAT) superfamily. Although the physiological function of AAC(2')-Ic is uncertain, a structural analysis of these high-affinity aminoglycoside complexes suggests that the enzyme may acetylate a key biosynthetic intermediate of mycothiol, the major reducing agent in mycobacteria, and participate in the regulation of cellular redox potential.
AAC(2')-Ic催化辅酶A(CoA)依赖性的多种氨基糖苷类2'羟基或氨基的乙酰化反应。结核分枝杆菌的AAC(2')-Ic晶体结构已通过无酶形式以及与CoA和妥布霉素、卡那霉素A或核糖霉素形成的三元复合物得以确定,这代表了氨基糖苷类乙酰转移酶与药物结合的首个结构。AAC(2')-Ic的整体折叠使其属于GCN5相关的N - 乙酰转移酶(GNAT)超家族。尽管AAC(2')-Ic的生理功能尚不确定,但对这些高亲和力氨基糖苷类复合物的结构分析表明,该酶可能会使分枝硫醇(分枝杆菌中的主要还原剂)的关键生物合成中间体乙酰化,并参与细胞氧化还原电位的调节。